Beclin-1 autophagy
Selected indexed studies
- CUL3 (cullin 3)-mediated ubiquitination and degradation of BECN1 (beclin 1) inhibit autophagy and promote tumor progression. (Autophagy, 2021) [PMID:33977871]
- Beclin-1: a therapeutic target at the intersection of autophagy, immunotherapy, and cancer treatment. (Front Immunol, 2024) [PMID:39650649]
- The beclin 1 interactome: Modification and roles in the pathology of autophagy-related disorders. (Biochimie, 2020) [PMID:32428566]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- CUL3 (cullin 3)-mediated ubiquitination and degradation of BECN1 (beclin 1) inhibit autophagy and promote tumor progression. (2021) pubmed
- Beclin-1: a therapeutic target at the intersection of autophagy, immunotherapy, and cancer treatment. (2024) pubmed
- The beclin 1 interactome: Modification and roles in the pathology of autophagy-related disorders. (2020) pubmed
- The Beclin 1 network regulates autophagy and apoptosis. (2011) pubmed
- The autophagy effector Beclin 1: a novel BH3-only protein. (2008) pubmed
- Autophagy induction via STING trafficking is a primordial function of the cGAS pathway. (2019) pubmed
- Activation of RIG-I-Mediated Antiviral Signaling Triggers Autophagy Through the MAVS-TRAF6-Beclin-1 Signaling Axis. (2018) pubmed
- Beclin 1 complex in autophagy and Alzheimer disease. (2010) pubmed
- Beclin-1-dependent autophagy, but not apoptosis, is critical for stem-cell-mediated endometrial programming and the establishment of pregnancy. (2023) pubmed
- Role for autophagy-related markers Beclin-1 and LC3 in endometriosis. (2022) pubmed